Expertise in
3
conditions

Leida D. Zhang

Chongqing, CN 
Expertise in
3
conditions
Chongqing, CN 

Overview

Leida Zhang practices practicing medicine in Chongqing, China.

Ms. Zhang is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Gallstones, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

She is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Chongqing, China
Other Locations
Jiangbei, 400020, China
Tanjiagang, China
Xinqiao, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Long Term Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Cholecystectomy for Choledocholithiasis: a Multicenter Prospected Non-randomized Controlled Study
A Long Term Comparison of Laparoscopic Common Bile Duct Exploration and Cholecystectomy Versus Sequential ERCP Followed by Cholecystectomy for Choledocholithiasis: a Multicenter Prospected Non-randomized Controlled Study
Enrollment Status: Completed
Publish Date: January 05, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Effect of Different Endoscopic Papillary Balloon Dilation Duration Time on Complications of Common Bile Duct Stone Patient
Effect of Different Endoscopic Papillary Balloon Dilation Duration Time on Complications of Common Bile Duct Stone Patient
Enrollment Status: Completed
Publish Date: January 25, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

69 Total Publications

Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma.
Comprehensive characterization of SLC41A3 identifies it as an immune-related prognostic biomarker and therapeutic target in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: April 21, 2026

Frequently Asked Questions about Leida D. Zhang

Is Leida D. Zhang a top-rated expert for Hepato-Pancreato-Biliary Surgery?

MediFind is an objective health platform that identifies experts based on real-world data. Leida D. Zhang is classified as an Advanced expert for Hepato-Pancreato-Biliary Surgery, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Leida D. Zhang participate in research or clinical trials?

Yes. Leida D. Zhang has published 69 articles and abstracts on conditions like Hepato-Pancreato-Biliary Surgery. You can view a list of Leida D. Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Zhang's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile